Effects of atorvastatin versus pravastatin on platelet inhibition by clopidogrel in patients with acute coronary syndrome after percutaneous coronary intervention.

Trial Profile

Effects of atorvastatin versus pravastatin on platelet inhibition by clopidogrel in patients with acute coronary syndrome after percutaneous coronary intervention.

Completed
Phase of Trial: Phase IV

Latest Information Update: 06 Nov 2008

At a glance

  • Drugs Atorvastatin (Primary) ; Clopidogrel (Primary) ; Pravastatin
  • Indications Acute coronary syndromes
  • Focus Adverse reactions
  • Most Recent Events

    • 06 Nov 2008 Trial end date changed from Apr 2008 to May 2008 as reported by Clinicaltrials.gov.
    • 06 Nov 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 31 Jan 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top